bioRxiv / medRxiv
open access
BRIDGE-AD reveals Alzheimer's disease effectors through interpretable large-scale omics integration
The growing landscape of Alzheimer's disease (AD) datasets creates opportunities to integrate heterogeneous evidence and systematically discover disease effectors. We present BRIDGE-AD, an interpretable network medicine framework that transforms multimodal data into a unified, disease-specific gene
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Robust transcriptomic signatures of Alzheimer's disease progression: validated explainable AI approach.#213872
- Multi-Omic Analyses Reveal Bidirectional Genetic Links and Convergent Inflammatory-Neuronal Signatures Between Frailty, Chronic Pain, and Rheumatoid Arthritis#417368
- SYNPRED: A Synergistic Approach to Multimodal Learning for Clinical Prediction#1068004
- Integrated multi-omics analysis identifies candidate eRNA-associated signatures shared between osteoarthritis and type 2 diabetes.#418294
- Precision Oncology: Targeting Genomic Alterations and Cancer Signaling with Integrative Multi-Omics, Deep Learning and Network Biology in Medical Oncology#406809
Record · ID 1381489
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive